Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 14 of 14 for “"SN38"”.
-
A combined lipophilic prodrug and lipid-based drug delivery approach to enable oral chemotherapy (with SN38)
… against CRC, 7-ethyl-10-hydroxycamptothecin (SN38), using nanomedicine and/or prodrug approaches. In particular, the thesis describes (i) the fabrication of a silica-lipid hybrid (SLH) delivery systems for SN38, with high drug loading by drug-surfactant complexation and determination of its in …
-
Pre-clinical Evaluation of Therapeutic Microbubbles for the Treatment of Colorectal Cancer
… and subsequently its active metabolite SN38. These drug-loaded MBs were termed therapeutic MBs (thMBs) and were specifically targeted to tumour vasculature using the pro- angiogenic receptor expressed by endothelial cells, vascular endothelial growth factor receptor-2 (VEGFR2). Once …
-
Development of Novel Peptide-Drug Conjugates for Targeting Brain Tumors and Brain Metastases
… peptide/peptoid-lapatinib and peptide/peptoid-SN38 conjugates to improve the delivery of lapatinib or SN-38 to the brain, and demonstrate antitumor efficacy in the breast cancer brain metastasis and glioblastoma mouse models. In this dissertation, we first developed Angiopep-2 peptide-based …
-
Self-assembly Polymeric Nanoparticles Composed of Polymers Crosslinked with Transition Metals for Use in Drug Delivery
… method to incorporate SN-38 into Co-alb (SN38 Co-Alb NPs). Release of the drug from SN38 Co-Alb NPs was determined for particles incubated in PBS or PBS-GSH. SN38 Co-Alb NPs were exceptionally stable under physiological condition (PBS pH 7.4), but exhibited sustained release of SN-38 over …
-
Synergistic effects of combining PARP inhibitor (AZD2281) and ATR inhibitor (AZD6738) in Ewing Sarcoma cell lines
… whether low dose genotoxic chemotherapy with SN38 can potentiate the anti-tumor effect of combined PARP and ATR inhibition in ES cell lines. We studied the anti-Ewing Sarcoma effect of the combination of a PARP inhibitor, AZD2281, and an ATR inhibitor, AZD6738, across a range of doses with and …
-
Synthesis and Characterization of Redox-Sensitive Polymer and Prodrug for Targeted Drug Delivery
… redox-sensitive self-immolative polymer, and DNS-SN38, thiol-sensitive SN-38 prodrug, as potential candidates for targeted drug delivery platforms. By covalently conjugating a redox-trigger (p-nitrobenzyl alcohol) and self-immolative linker (p-hydroxybenzyl alcohol) to the cyclization spacer …
-
Avaliação genotípica e fenotípica da farmacocinética do irinotecano e sua relação com a ocorrência de toxicidade no tratamento do câncer
… avaliação dos pontos de corte da razão de dose [SN38] / IRI para identificar qualquer evento adverso grave e diarreia foi definida usando a área sob a análise da curva característica operada pelo receptor (ROC). Um valor de P ≤ 0,05 foi considerado estatisticamente significativo. Resultados …
-
POLY (AMIDO AMINE) DENDRIMERS: TRANSEPITHELIAL TRANSPORT MECHANISMS AND APPLICATIONS IN ORAL DRUG DELIVERY
… by the evaluation of G3.5 PAMAM dendrimer-SN38 conjugates for oral therapy of hepatic colorectal cancer metastases, a pathology present in over 50% of colorectal cancer cases that is responsible for two-thirds of deaths. Conjugation of SN38, a potent chemotherapy drug with poor solubility …
-
Development of an In Vitro 3-Dimensional Co-Culture Human Colorectal Cancer Model in Microfluidic Devices
… of the chemotherapeutic agents oxaliplatin and SN38 on the tumor and endothelial cells in 2D. After the various densities and drug concentrations were tested in 2D, the model was introduced into microfluidic devices. The first experiment in the devices was similar to the first experiment plated …
-
Role of De Novo Fatty Acid Synthesis in Intrinsic Activation of EGFR in Cancer
… of EGFR in response to anticancer drugs such as SN38 and oxaliplatin dependent on de novo fatty acid synthesis. Finally, targeting de novo fatty acid synthesis or palmitoylation significantly increased the sensitivity of cancer cells to EGFR TKIs or anticancer drugs. In conclusion, through this …
-
Elucidating the Role of RNA Binding Proteins in Maintaining Genome Integrity
… flavopiridol, and the DNA damage agent, SN38. This combination drastically diminished cell viability in Ewing cell lines. This sensitivity was not found in non-Ewing cell lines U2OS and HEK293T/17. We also find in Ewing cells that the combination treatment decreases the DNA damage markers …
-
Highly-functional Poly(amino acids) for Controlled Therapeutic Drug Delivery
… enabling efficient carbamate conjugation to SN38. The resulting conjugates formed uniform nanoparticles that exhibited excellent stability and sustained release under physiologically relevant conditions.
-
Pharmacometric modeling of anti-cancer agents: application to gemcitabine, PQIP and irinotecan.
… of irinotecan and its metabolites SN38 and APC in plasma and CSF in rats. The concentration-time data in plasma and CSF were analyzed by nonlinear mixed-effects modeling using FOCE-I method in NONMEM. The analysis showed that cranial radiation delivered during irinotecan …